Health Care & Life Sciences » Pharmaceuticals | Imprimis Pharmaceuticals Inc.

Imprimis Pharmaceuticals Inc. | Ownership

Companies that own Imprimis Pharmaceuticals Inc.

Name
Shares Held
% Shares Out
Change In Shares
% of Assets
As of Date
Longboard Capital Advisors LLC
1,156,000
5.49%
-52,000
12.04%
04/30/2018
Opaleye Management, Inc.
1,075,000
5.11%
-175,000
0.82%
08/29/2018
The Vanguard Group, Inc.
708,086
3.36%
28,720
0%
06/30/2018
Birchview Capital LP
180,000
0.86%
180,000
0.33%
06/30/2018
Granite Investment Partners LLC
170,962
0.81%
103,607
0.03%
06/30/2018
Institutional & Family Asset Management LLC
162,859
0.77%
31,666
0.1%
06/30/2018
Berson & Corrado Investment Advisors LLC
101,239
0.48%
-9,010
0.09%
06/30/2018
Ardsley Advisory Partners
100,000
0.48%
30,000
0.05%
06/30/2018
BlackRock Fund Advisors
79,985
0.38%
8,338
0%
06/30/2018
Jacob Asset Management of New York LLC
71,389
0.34%
20,000
0.25%
02/28/2018

About Imprimis Pharmaceuticals

View Profile
Address
12264 El Camino Real
San Diego California 92130
United States
Employees -
Website http://www.imprimispharma.com
Updated 09/14/2018
Imprimis Pharmaceuticals, Inc. engages in the development, production, and dispensing of innovative proprietary compounded pharmaceuticals. The company was founded by Mark L. Baum and Robert J.

StatInvestor

Privacy Policy
Feedback

© 2024 StatInvestor All Rights Reserved.